Navigating Novel Modalities: CRO Expertise in Cell, Gene, and Advanced Biologic Therapies
The rapid scientific advancement in biologics, particularly the groundbreaking field of cell and gene therapy, represents a critical driver for the US contract research sector. These novel therapeutic modalities introduce significant complexity in manufacturing, regulatory submission, and clinical execution that require specialized expertise beyond traditional small-molecule drug trials. CROs...
0 Commentaires 0 Parts 979 Vue 0 Aperçu